MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12967-026-08039-8

Медицинская библиотека · Journal of translational medicine · 2026

Efficacy of LNP@2DG-DON liposomal nanoparticles in tumor inhibition and immune activation.

Li Jianang, Feng Jiale, Liu Runjie, Du Yueshan, Li Yueheng, Liu Liang, Zhang Lei

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Pancreatic cancer has poor prognosis, and immunotherapy efficacy is limited by PD-L1 stability via GFAT1-mediated glycosylation. We developed LNP@2DG-DON, a liposomal nanoparticle co-delivering glycolysis inhibitor 2DG and GFAT1 inhibitor DON, to enhance antitumor immunity and metabolic targeting.

METHODS

LNP@2DG-DON nanoparticles were synthesized using the thin-film dispersion method and characterized for size, stability, drug loading, and release profiles. In vitro studies assessed cytotoxicity, apoptosis, migration, and invasion in ASPC-1 and PANC-1 pancreatic cancer cell lines. In vivo efficacy was evaluated in a subcutaneous xenograft mouse model, measuring tumor growth, immune cell infiltration, and survival. Western blotting, flow cytometry, and immunohistochemistry were employed to analyze molecular and cellular mechanisms.

RESULTS

LNP@2DG-DON showed uniform size (100-120 nm), high drug loading (6.84-9.27%), and sustained release. It significantly reduced cell viability, induced apoptosis, and inhibited metastasis in vitro. In vivo, it suppressed tumor growth, prolonged survival, and increased CD8+/NK cell infiltration while reducing immunosuppressive cells. Mechanistically, it downregulated PD-L1/GFAT1 and activated pro-apoptotic pathways.

CONCLUSIONS

The dual-targeting LNP@2DG-DON nanoparticle synergistically combines metabolic and immune modulation, demonstrating superior antitumor effects compared to single-agent therapies. This approach represents a promising strategy for pancreatic cancer treatment, warranting further clinical investigation.

Для цитирования: Li Jianang, Feng Jiale, Liu Runjie, Du Yueshan, Li Yueheng, Liu Liang, Zhang Lei. Efficacy of LNP@2DG-DON liposomal nanoparticles in tumor inhibition and immune activation.. Journal of translational medicine. 2026. DOI: 10.1186/s12967-026-08039-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.